FSD Pharma begins construction of heritage museum and flagship dispensary in Ontario

FSD Pharma Inc. (“FSD Pharma”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), announced today the launch of a clinical research collaborative program in Israel, via its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”) This comprehensive clinical research program will be executed…